Watch · Quality 21/100
Simple research view
EW · Edwards Lifesciences Corporation
$87.84 latest stored close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$EW
Edwards Lifesciences CorporationEdwards Lifesciences Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $51B.
Council read · 6 methods
Watch — evidence is building
0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.
Earnings-risk mode
Normal technical setup
Thursday, July 23, 2026
Time not confirmed
No sourced report session or clock time
Deterministic evidence
EW+0.65%
Sector proxy · XLV+2.22%
Broad market · SPY-0.54%
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.EW Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Setup Quality
B
4/7 signals
Score trend
✓
Stage 2 · Advancing
✗
Power Trend
✗ RS New High
✓ Trend 6/8
✗
No Pattern
✓ CANSLIM 71.2 (B)
✓ Gatekeeper
Base #2 (B)
Technical Analysis Report Card
$EW · $87.84 · as of 2026-07-16 · multi-factor read
53
/ 100
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▲ Uptrend
Monthly
▬ Sideways / consolidating
Moving Averages
50-day$86.85 ↑
100-day$84.52 ↑
200-day$83.20 ↑
Bullish (50 > 200)
RSI (14)
Reading45.0 · Bearish
Bearish momentum — sellers in control.
MACD (12/26/9)
StateWeakening
Histogram-0.732
Weakening — MACD slipped below its signal line. Histogram contracting.
Bollinger Bands (20,2)
%B / Width27% · 12.5%
Mid-band — no directional band edge in play.
Volume · Buyer vs Seller
Up/Down vol0.89 · Neutral
Rel volume1.21×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
Support & Resistance
R · $89.48swing level
R · $96.2952-week high
Price · $87.84now
S · $83.17swing level
S · $80.88swing level
S · $77.20swing level
Fibonacci · Uptrend swing
23.6%$91.19
38.2% ◄ price here$88.03
50.0%$85.47
61.8%$82.92
78.6%$79.29
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for EW — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Weekly uptrendAbove 200-day MA50/200 bullishRS 30 (laggard)
Want this read in a legend's voice?
💬 Ask a Legend about EW
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C
Trend-template read: 9/13 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $87.84, MA150 $83.97, MA200 $83.20
1.2 150-day MA > 200-day MAMA150 $83.97 vs MA200 $83.20
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 30
2. ROE ≥ 17%ROE 10.6%
Avoid
O'Neil D
CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+34.5% QoQ
N: Near 52-week high or RS line new high8.8% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 30
A: Annual earnings & revenue qualityRev +11.6% | ROE 10.6%
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $87.84 vs MA200 $83.20
Failing evidence
Volume expansion above averageVolume ratio 1.21x
Relative strength ≥ 60RS 30
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$87.84
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 30
Volume vs average1.21x
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$87.84
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 30
Volume vs average1.21x
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$87.84
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 30
Volume vs average1.21x
Breakout Health
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
🕯 Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +5
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B
4/7 SEPA
Separate score from the 8-point Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+34%
Revenue growth ≥20% YoY
+12%
Gross margin ≥30%
78%
ROE ≥17%
11%
RS rating ≥80 (leadership)
30
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-8.8%
Method Playbook
📋 Trade it like Wyckoff
EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis (historical · 11d ago)
67.9
score
RS Score
30
Trend
6/8 ✓
CANSLIM
71.2* (B)
range low: 77.399
range high: 84.972
range pct: 0.098
sos thrust: 0.068
sos vol ratio: 2.904
sos bars ago: 13
near lps: ✓
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
D+W Confluence
Wyckoff SOS
SOS: breakout above range_high=84.97, thrust=6.8%, vol=2.9x avg, lps=near, 13 bars ago | Moderate trend (6/8) | High-confidence pattern (95%) | Stage 2 | Readiness 67/100 (watch) | CANSLIM 71.2 (B)
The Universal Edge Check
The panel is uneasy
Too many universals unmet — this leans closer to a guess than a trade.
1/7
universals met
- In a confirmed uptrend Stage 2 · Trend 6/8
- Risk is defined No stop — undefined risk
- Asymmetric reward No target set
- Not chasing (in range) Pivot distance unknown
- Volume confirms 1.2× average — light
- Clear of earnings in -5 days — event risk
- A relative-strength leader RS 33 — laggard
Minervini Trend Template
6/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$87.84 vs SMA150 $83.97 / SMA200 $83.20
SMA 150 above SMA 200
SMA150 $83.97 vs SMA200 $83.20
SMA 200 trending up
Slope +1.30 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $86.85
Price above SMA 50
$87.84 vs SMA50 $86.85
30%+ above 52W low
+21.5% from $72.30
Within 25% of 52W high
-8.8% from $96.29
RS score above 70
RS 30
Fundamentals
52W Range
65%
Mkt Cap SEC
50.6B
EPS QoQ
+34%
Rev YoY
+12%
ROE
11%
Gross Margin
78%
D/E
0.06
EPS TTM
$1.83
P/E TTM
48.0x
Float
576M
Insider
No Buy
Company
Legend AI snapshot
Edwards Lifesciences Corporation
$87.84latest close
$50.6Bmarket cap
33RS rank
68setup score
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
71.2* CANSLIM
* disqualified on M
C · Curr. EPS
100
A · Annual EPS
69
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
30
I · Inst. Spons.
96
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
6/8
W. RS
69
W. Support
$74.66
W. Resist
$96.29
W. Patterns
Basing
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
Jul 17
Wyckoff SOS
✓ Gate
68
Jul 16
Wyckoff SOS
✓ Gate
72
0.0%
Jul 16
Wyckoff SOS
✓ Gate
71
0.0%
Jul 16
Wyckoff SOS
✓ Gate
71
0.0%
Jul 15
Wyckoff SOS
✓ Gate
60
+0.7%
Jul 15
Wyckoff SOS
✓ Gate
60
+0.7%
Get the full picture on EW
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.
Start 7-Day Free Trial